Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Current Assets (2016 - 2026)

Tenax Therapeutics' Current Assets history spans 6 years, with the latest figure at $8.1 million for Q4 2017.

  • On a quarterly basis, Current Assets fell 40.84% to $8.1 million in Q4 2017 year-over-year; TTM through Dec 2017 was $8.1 million, a 40.84% decrease, with the full-year FY2017 number at $8.1 million, down 40.84% from a year prior.
  • Current Assets hit $8.1 million in Q4 2017 for Tenax Therapeutics, down from $8.7 million in the prior quarter.
  • Over the last five years, Current Assets for TENX hit a ceiling of $20.6 million in Q4 2015 and a floor of $1.7 million in Q1 2013.
  • Historically, Current Assets has averaged $9.4 million across 4 years, with a median of $8.8 million in 2017.
  • Biggest five-year swings in Current Assets: tumbled 61.87% in 2013 and later rose 12.99% in 2017.
  • Tracing TENX's Current Assets over 4 years: stood at $1.8 million in 2013, then skyrocketed by 1016.05% to $20.6 million in 2015, then tumbled by 33.72% to $13.6 million in 2016, then tumbled by 40.84% to $8.1 million in 2017.
  • Business Quant data shows Current Assets for TENX at $8.1 million in Q4 2017, $8.7 million in Q3 2017, and $9.0 million in Q2 2017.